insights_auto
Por qué ha bajado 2359 2,19%?
Profundizarchevron_right
2359:HKG
WuXi AppTec Ord Shs H
196,20 HKD
arrow_downward
-2,19%(-4,40) 1 d
16 oct, 16:08:14 GMT+8 · HKD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de 2359...
Abrir
203,80 HKD
Alto
209,00 HKD
Bajo
185,00 HKD
Cap. burs.
544,52 mil M
Vol. medio
3,91 M
Volumen
10,16 M
Dividendo
1,22 %
Dividendo trimestral
0,60 HKD
Fecha exdividendo
4 sept 2026
Ratio PER
23,98
Máximo en 52 sem.
219,20 HKD
Mínimo en 52 sem.
96,70 HKD
BPA
8,18 HKD
N.º de empleados
36 mil
Abrir
203,80 HKD
Alto
209,00 HKD
Bajo
185,00 HKD
Cap. burs.
544,52 mil M
Vol. medio
3,91 M
Volumen
10,16 M
Dividendo
1,22 %
Dividendo trimestral
0,60 HKD
Fecha exdividendo
4 sept 2026
Ratio PER
23,98
Máximo en 52 sem.
219,20 HKD
Mínimo en 52 sem.
96,70 HKD
BPA
8,18 HKD
N.º de empleados
36 mil
Noticias
De fuentes web y partners de noticias
ad-hoc-news.de
·
hace 1 día
Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40
ad-hoc-news.de
·
hace 2 días
Morgan Stanley backs 800-ton expansion for WuXi AppTec stock
Perfil
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
Acerca de WuXi AppTec Ord Shs H